Adults with high levels of HbA1c may be at risk of lowered adherence to diabetes medication during poor management of depression.
Read More »Yearly Archives: 2019
How Many Steps Are Needed to Improve Quality of Life for 70-Year-Olds?
Older adults with diabetes may be able to benefit from specific exercise recommendations.
Read More »Elevated Depressive Symptoms and Disability Among Patients Newly Diagnosed with Diabetes
Depression and new diagnosis of diabetes in older adults can increase time to disability.
Read More »Feasibility of Incorporating Personalized Health Planning into Shared Medical Appointments for Patients Who Have T2
Study compares enhanced patient care experience with standard shared medical appointments to determine if a significant benefit will result.
Read More »Large-Scale Study Clarifies Polycystic Ovary Syndrome Diagnosis
Diabetes in Control is pleased to bring you an exclusive interview with Dr. Andrea Dunaif, the Lillian and Henry M. Stratton Professor of Molecular Medicine and Chief of the J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dunaif is an internationally recognized expert in endocrinology and women’s health. Her research on polycystic ovary syndrome (PCOS), the most common hormonal disorder of reproductive-age women, has shown that it is a leading risk factor for type 2 diabetes mellitus. Further, this research has revolutionized the treatment of PCOS with insulin-sensitizing drugs.
Read More »Defining Obesity
Is obesity a disease or a lifestyle choice? Follow the link to share your opinion and see what your colleagues think.
Read More »Type 2 Medication Risks
Which of the following commonly prescribed drugs to treat type 2 diabetes carries a high risk of cardiovascular events, including heart attack, stroke, heart failure, or amputation, according to a recent study?
- Basal insulin
- Biguanides
- Meglitinide derivatives
- Alpha-glucosidase inhibitors
- Glucagon-like peptide–1 (GLP-1) agonists
- Dipeptidyl peptidase IV (DPP-4) Inhibitors
- Selective sodium-glucose transporter-2 (SGLT-2) inhibitors
Follow the link for the answer.
Read More »FDA Panel Has Tie Vote on New Type 1 Diabetes Drug
Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels
Read More »Trained Alert Dogs Can Detect Impending T1DM-Related Events
In study, individual dogs' performance varied for detecting hypoglycemic episodes, hyperglycemia
Read More »Oral Hepatoselective Glucokinase Activator Promising in T2DM
Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.